Dov Gertz
Founder · Converge Bio · Tel Aviv-Yafo, Tel Aviv, Israel
Contact Details
Why reach out now
Fresh capital means vendor and tool decisions are happening right now.
Open roles signal budget is being allocated across the org.
Most founders lock in key vendors within 60 days of closing a round.
About Dov Gertz
Dov Gertz is the founder of Converge Bio, a biotechnology research startup founded in 2024 and based in Tel Aviv-Yafo, Tel Aviv, Israel. The company most recently raised $25M in a Series A round (Jan 13, 2026). This profile is part of JustRaised — a verified database of funded founders updated daily for sales, recruiting and partnerships.
Why reach out to Dov now
Founders typically evaluate new tools, hire aggressively, and lock in vendor relationships within the first 90 days of closing a round. Converge Bio raised 139 days ago, putting Dov squarely inside that buying window. Reach out with a concise, relevant message that references the raise and the specific problem you solve for Biotechnology Research companies.
Frequently asked questions
- Who is Dov Gertz?
- Dov Gertz is the founder of Converge Bio, working in the biotechnology research space.
- How much did Converge Bio raise?
- Converge Bio raised $25M in a Series A round on Jan 13, 2026.
- How do I contact Dov?
- Verified email and LinkedIn for Dov Gertz are available on a JustRaised paid plan, alongside 1,000+ other recently funded founders.